(63 days)
No
The device description and performance studies focus on the physical properties and function of tubing for fluid flow, with no mention of AI or ML.
No.
The device is a component of a cardiopulmonary bypass circuit, which is used to support life functions, but the tubing itself is not designed to directly treat a disease or condition. It acts as a conduit for fluid flow within a larger therapeutic system.
No
The device is described as tubing to provide a conduit for fluid flow during cardiopulmonary bypass procedures, not to diagnose a condition. Its function is to facilitate fluid movement within a medical circuit.
No
The device description clearly states it is a physical tubing segment made of flexible polyvinyl chloride (PVC) resin, intended to provide a conduit for fluid flow. This is a hardware component, not software.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states the tubing is for providing a conduit for extracorporeal fluid flow during cardiopulmonary bypass procedures. This is a procedure performed on a patient, not a test performed on a sample taken from a patient.
- Device Description: The description reinforces its use as a conduit for fluid flow within a bypass circuit, which is part of a medical procedure.
- Lack of IVD Characteristics: There is no mention of analyzing samples (blood, tissue, etc.), detecting substances, or providing diagnostic information based on testing a sample.
IVD devices are used to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. This tubing is a component used in a surgical procedure on the body itself.
N/A
Intended Use / Indications for Use
The Terumo® Circuit Tubing is intended to provide a conduit for extracorporeal fluid flow during cardiopulmonary bypass procedures when interconnecting components of the bypass circuit.
The tubing is intended to be used in procedures lasting not more than 6 hours.
Product codes
DWF
Device Description
The Terumo® Circuit Tubing that is the subject of this application uses the same technology as the predicate Terumo® Circuit Tubing that is the subject of K023056. Both are tubing segments that provide a conduit for the flow of extracorporeal fluids within the bypass circuit. Each of the tubing segments is typically used as a conduit between other devices within the circuit. Each tubing allows for the flow of fluids created by either gravity, vacuum and pumping.
The blood-contacting material that is used in the construction of the Terumo® Circuit Tubing is flexible polyvinyl chloride (PVC) resin.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Terumo Cardiovascular Systems conducted the following in-vitro performance evaluations to demonstrate the functional equivalence of the subject Terumo® Circuit Tubing to the predicate Terumo® Circuit Tubing.
- Tubing Connection Strength .
- Leakage Testing .
- . Dimensional Analysis
- Visual for abnormalities .
Key Metrics
Not Found
Predicate Device(s)
Terumo® Circuit Tubing, Part Number 0017-11031A.
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.4210 Cardiopulmonary bypass vascular catheter, cannula, or tubing.
(a)
Identification. A cardiopulmonary bypass vascular catheter, cannula, or tubing is a device used in cardiopulmonary surgery to cannulate the vessels, perfuse the coronary arteries, and to interconnect the catheters and cannulas with an oxygenator. The device includes accessory bypass equipment.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features the department's name in a circular arrangement around a stylized symbol. The symbol consists of three overlapping profiles facing to the right, with flowing lines extending from the bottom of the profiles.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
May 5, 2015
Terumo Cardiovascular Systems Corporation Garry A. Courtney, MBA, RAC Senior Manager, Regulatory Affairs 125 Blue Ball Road Elkton, MD 21921
Re: K150536
Trade/Device Name: Terumo Circuit Tubing Regulation Number: 21 CFR 870.4210 Regulation Name: Cardiopulmonary Bypass Vascular Catheter, Cannula, or Tubing Regulatory Class: Class II Product Code: DWF Dated: April 2, 2015 Received: April 7, 2015
Dear Mr. Courtney:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical
1
device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
for
Sincerely yours,
M.A. Hillebrenner
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
TERUM
SU NOITOSTS
10(k) (quanber (f known); 985051 X
evice Name: Ferumo® Circuit Tubing
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
smod o until a mom tou quites se mber of to to population in guidul an
(□ ਸ਼ਵਰ੍
(၁ ກິໂລແມັນ
ిని స్టే
್ತಿತ
ir
อนๆ คลิทางกล F
DO) noitanleva esived to esived to esvice to essering (OO
:
の出会い
20 25
ा
D
3
Image /page/3/Picture/0 description: The image shows the Terumo Corporation logo. The logo consists of a green circle with a stylized "T" inside, followed by the word "TERUMO" in green, sans-serif font. The logo is simple and modern, and the green color suggests health and vitality.
Primary Contact:
This submission was prepared in March 2015 by: Garry A. Courtney, MBA, RAC Sr. Manager, Regulatory Affairs Terumo Cardiovascular Systems Corporation 125 Blue Ball Road Elkton, MD 21921 Telephone: 1-800-262-3304, Ext. 7486 Fax: 410-398-6079
This submission was prepared for: Terumo Cardiovascular Systems Corporation 28 Howe Street Ashland, MA 01721
Device Names/Classifications:
| Proprietary Name | Classification Name | Common Name |
|---|---|---|
| Terumo® Circuit Tubing | Cardiopulmonary Bypass | |
| Catheter, Cannula or Tubing | Circuit Tubing |
Predicate Device(s):
The device submitted in this 510(k) maintains characteristics that are substantially equivalent to the following devices:
- Terumo® Circuit Tubing, Part Number 0017-11031A. This tubing has preamendment . status as the product was included in Convenience Kits manufactured by Terumo Cardiovascular since prior to May 28, 1976.
Indications for Use:
The Terumo® Circuit Tubing is intended to provide a conduit for extracorporeal fluid flow during cardiopulmonary bypass procedures when interconnecting components of the bypass circuit.
The tubing is intended to be used in procedures lasting not more than 6 hours.
Conditions of Use:
The Terumo® Circuit Tubing can be used in any cardiopulmonary bypass procedure where an extracorporeal circuit is required and where the conduit tubing necessary is 3/32" wall thickness.
Principles of Operation and Technology:
The Terumo® Circuit Tubing that is the subject of this application uses the same technology as the predicate Terumo® Circuit Tubing that is the subject of K023056. Both are tubing segments that provide a conduit for the flow of extracorporeal fluids within the bypass circuit. Each of the tubing segments is typically used as a conduit between other devices within the circuit. Each tubing allows for the flow of fluids created by either gravity, vacuum and pumping.
4
Image /page/4/Picture/0 description: The image shows the Terumo Corporation logo. The logo consists of a green circle with a stylized "T" inside, followed by the word "TERUMO" in green, sans-serif capital letters. A small registration mark is present to the right of the word "TERUMO".
Design and Materials:
The blood-contacting material that is used in the construction of the Terumo® Circuit Tubing is flexible polyvinyl chloride (PVC) resin.
The design differences between the subject Terumo® Circuit Tubing and predicate Terumo® Circuit Tubing device is the tubing dimensions and the durometer (tubing hardness). The differences are presented below:
| Device Characteristics | Subject: 0017-40152 | Predicate: 0017-11031A |
|---|---|---|
| Materials of Construction | Flexible PVC resin | Flexible PVC resin, PMEA Coating |
| Shore A Durometer Hardness Measurement | 68 | 70 |
| Tubing Dimensions | ||
| (I.D. x wall thickness) | 3/32" x 1/32" | 3/32" x 1/16" |
Performance Evaluations:
Terumo Cardiovascular Systems conducted the following in-vitro performance evaluations to demonstrate the functional equivalence of the subject Terumo® Circuit Tubing to the predicate Terumo® Circuit Tubing.
- Tubing Connection Strength .
- Leakage Testing .
- . Dimensional Analysis
- Visual for abnormalities .
Substantial Equivalence Comparison:
In demonstrating substantial equivalence of the Terumo® Circuit Tubing to the predicate Terumo® Circuit Tubing a comparative study and/or assessment was performed in each of the following areas:
- Indications for Use .
- o Duration of use
- . Target population
- Product labeling .
- Product design .
- Materials used in device construction .
- Principles of Operation and Technology .
- Device Performance .
Substantial Equivalence Statement:
The new Terumo® Circuit Tubing is substantially equivalent in product indications, target population, duration of use, labeling, design, materials, principles of operation and technology, and performance to the predicate Terumo® Circuit Tubing (Preamendment).
5
Image /page/5/Picture/0 description: The image shows the Terumo Corporation logo. The logo consists of a green circle with a stylized "T" inside, followed by the word "TERUMO" in green, sans-serif capital letters. A registered trademark symbol is located to the right of the word "TERUMO".
Additional Safety Information:
- Sterilization conditions for the Terumo® Circuit Tubing will be validated in accordance with . applicable standards and guidelines to provide a Sterility Assurance Level (SAL) of 10°. Terumo Cardiovascular Systems further asserts that the ethylene oxide residues will not exceed stated or implied maximum residue limits at the of product distribution.
Conclusion:
Based upon the comparative studies and analyses, Terumo Cardiovascular Systems concludes that the Terumo® Circuit Tubing is substantially equivalent to the predicate Terumo® Circuit Tubing. It is further concluded that any recognized differences noted during the assessments do not raise new issues of patient/user safety or product effectiveness.